Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,217 | 1,271 | 960 | 1,842 | 2,380 |
| Receivables | 80 | 57 | 90 | 56 | 81 |
| Inventories | 417 | 471 | 497 | 610 | 575 |
| Other current assets | 38 | 97 | 88 | 15 | 13 |
| TOTAL | $2,770 | $1,896 | $1,636 | $2,523 | $3,050 |
| Non-Current Assets | |||||
| PPE Net | 19 | 26 | 30 | 1,893 | 1,646 |
| Other Non-Current Assets | 130 | 167 | 203 | 325 | 590 |
| TOTAL | $148 | $193 | $233 | $2,218 | $2,236 |
| Total Assets | $2,918 | $2,089 | $1,869 | $4,741 | $5,285 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 34 | N/A |
| Accounts payable and accrued liabilities | 1,925 | 943 | 343 | 258 | 121 |
| TOTAL | $1,925 | $943 | $343 | $995 | $915 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,925 | $943 | $343 | $995 | $915 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 913 | 735 | 727 | 588 | 546 |
| Common Shares | 9 | 7 | 7 | 6 | 5 |
| Retained earnings | -17,588 | -13,333 | -9,500 | -5,276 | -2,724 |
| Other shareholders' equity | -130 | 0 | 0 | 0 | 0 |
| TOTAL | $993 | $1,146 | $1,526 | $3,746 | $4,370 |
| Total Liabilities And Equity | $2,918 | $2,089 | $1,869 | $4,741 | $5,285 |